Skip to content
PubMed This is a summary of 40 peer-reviewed journal articles Updated
Medical Genetics · MICU1-Related Myopathy with Extrapyramidal Signs

MICU1-Related Myopathy with Extrapyramidal Signs (MPXPS): A Patient Guide

At a Glance

MPXPS is a rare MICU1-related genetic disorder that commonly causes persistent muscle weakness, fatigue, and high creatine kinase levels, while movement symptoms vary. There is no cure yet, but tailored therapies and careful anesthesia planning support safety and daily function.

Receiving a diagnosis of a rare genetic disorder is life-changing, and it is completely normal to feel overwhelmed by the medical terminology. MICU1-Related Myopathy with Extrapyramidal Signs (MPXPS) is an exceptionally rare condition that affects how the “power plants” of the cells, the mitochondria, manage energy.

In a healthy cell, the MICU1 protein acts as a gatekeeper, helping to regulate calcium entering the mitochondria to boost energy production. When this protein is missing or non-functional, the mitochondria lose their ability to regulate this flow. Research in models suggests this leads to a state of cellular stress that primarily impacts the muscles and the brain [1][2].

While the condition’s name includes “Extrapyramidal Signs”—which refers to movement disorders like chorea or dystonia—the way the disease looks is highly variable. Most children experience persistent muscle weakness and tire much more easily than their peers, but roughly half of reported patients do not develop these movement issues [3][4]. This variability means that two children with the exact same genetic change can have very different daily experiences, with symptoms ranging from mild fatigue to more significant physical and learning challenges [3][5].

A hallmark of this condition that often leads to its discovery is a persistently elevated level of creatine kinase (CK) in the blood. This enzyme leaks from muscle cells when they are under stress, serving as a biological marker even when weakness is mild. Because MPXPS is so rare, many families spend years searching for an answer before genetic testing finally identifies the MICU1 variant. While there is currently no cure, a dedicated team of specialists can help manage symptoms through individualized physical, occupational, and speech therapies tailored to your child’s specific needs [5][6].

Living with MPXPS also requires a proactive approach to safety, particularly regarding medical procedures. Because the muscles are uniquely sensitive, specific medications used in anesthesia, such as succinylcholine, must be strictly avoided to prevent serious complications [7]. By building a knowledgeable care team and securing an individualized emergency and anesthesia plan, you can help ensure your child navigates both daily life and medical challenges safely. While the long-term course remains uncertain, focusing on supportive care and symptom management can help your child maximize their function and well-being [7][8].

Common questions in this guide

What is MICU1-related myopathy with extrapyramidal signs?
MPXPS is an exceptionally rare genetic disorder caused by a missing or nonfunctional MICU1 protein. This disrupts calcium control in the cell’s energy centers and can affect muscles and the brain.
What symptoms can a child with MPXPS develop?
Most children have persistent muscle weakness and tire more easily than their peers. Some develop movement problems such as chorea or dystonia, and some have learning or other physical challenges; about half of reported patients do not develop these movement signs.
How is MPXPS diagnosed?
A persistently high creatine kinase, or CK, level can be an important clue because it indicates stress in muscle cells, even when weakness is mild. Genetic testing can identify a MICU1 variant and help establish the diagnosis alongside the child’s symptoms and clinical evaluation.
Is there a cure or treatment for MPXPS?
There is currently no cure for MPXPS. A coordinated care team can tailor physical, occupational, and speech therapies, along with other supportive measures, to help manage symptoms and maximize daily function and well-being.
What anesthesia precautions are needed for a child with MPXPS?
Succinylcholine should be strictly avoided because the muscles may be unusually sensitive to it and serious complications can occur. Families should give every surgical or emergency team an individualized anesthesia and emergency plan before a procedure.
How can families coordinate school, therapy, and daily care for MPXPS?
Families can work with the care team and school to distinguish MPXPS-related fatigue from ordinary tiredness and to plan activity, rest, and needed support. Identifying a lead clinician or coordinator can help keep monitoring, therapies, and safety plans aligned.

Get notified when new evidence is published on Proximal myopathy with extrapyramidal signs.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Molecular pathophysiology of human MICU1 deficiency.

    Kohlschmidt N, Elbracht M, Czech A, et al.

    Neuropathology and applied neurobiology 2021; (47(6)):840-855 doi:10.1111/nan.12694.

    PMID: 33428302
  2. 2

    A Middle Eastern Founder Mutation Expands the Genotypic and Phenotypic Spectrum of Mitochondrial MICU1 Deficiency: A Report of 13 Patients.

    Musa S, Eyaid W, Kamer K, et al.

    JIMD reports 2019; (43()):79-83 doi:10.1007/8904_2018_107.

    PMID: 29721912
  3. 3

    Bi-Allelic Variants in MICU1 Cause Myopathy With Extrapyramidal Signs: Case Series, Phenotypic Spectrum, and Genotype-Phenotype Correlations From 61 Patients.

    Beheshti P, Akbarian F, Esmaeilzadeh E, et al.

    Clinical genetics 2026; (109(3)):564-570 doi:10.1111/cge.70062.

    PMID: 40898676
  4. 4

    MICU1 related myopathy - a rare report from India.

    Baskar D, Ganji SR, Thomas A, et al.

    Journal of neuromuscular diseases 2024; (11(6)):1295-1299 doi:10.1177/22143602241288400.

    PMID: 39973469
  5. 5

    Compound heterozygous mutations in MICU1 cause myopathy with extrapyramidal signs in two Chinese pedigrees.

    Li J, Liu H, Gan X, et al.

    Frontiers in neurology 2025; (16()):1624830 doi:10.3389/fneur.2025.1624830.

    PMID: 41018190
  6. 6

    Dolichocephaly, Arachnodactyly, Diplopia, and Distal Myopathy - Novel Phenotype of MICU1 Variant c.553C>T.

    Finsterer J, Barwari A

    Cureus 2024; (16(1)):e52672 doi:10.7759/cureus.52672.

    PMID: 38380193
  7. 7

    Anaesthetic management of patients with myopathies.

    Schieren M, Defosse J, Böhmer A, et al.

    European journal of anaesthesiology 2017; (34(10)):641-649 doi:10.1097/EJA.0000000000000672.

    PMID: 28719515
  8. 8

    Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

    Parikh S, Goldstein A, Karaa A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(12)) doi:10.1038/gim.2017.107.

    PMID: 28749475

This MPXPS information is for educational purposes only and does not constitute medical advice. Your child’s genetics and care team should tailor therapies, emergency guidance, and anesthesia precautions to their specific needs.